SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

Share Price is delayed by 15 minutes
Get Live Data
129.00    0.00 (0.00%)
Bid:
127.00
Ask:
131.00
Spread: 4.00 (3.15%)
Market Cap: £1.18b
NBS Live PriceLast checked at - London Stock Exchange

Intraday Nationwide Ccds Share Chart

Non Executive Director Changes

2 Sep 2019 07:00

RNS Number : 7728K
Nationwide Building Society
02 September 2019
 

2 September 2019

 

 

Nationwide Building Society announces Non-Executive Director changes

 

After more than eight years on the board, Lynne Peacock, Senior Independent Director and Chair of the Remuneration Committee, will retire from Nationwide at the end of 2019. Lynne will be succeeded as Chair of the Remuneration Committee from 16 September by fellow non-executive director, Mai Fyfield. Mai has been on the board for four years and has been a member of the Remuneration Committee for the last 12 months. She was previously Chief Commercial and Chief Strategy Officer at Sky. The appointment of the Society's Senior Independent Director will be announced closer to the date of Lynne's retirement.

 

In addition, Nationwide Building Society welcomes Phil Rivett to the board as a non-executive director with effect from 1 September. Phil spent more than 40 years at PricewaterhouseCoopers, retiring from his role as Chairman of Global Financial Services last year.

 

David Roberts, Chairman of Nationwide, said: 'Ensuring we have different perspectives around our board table can only strengthen our position to serve members now and in the future. We're very grateful for the insight and experience that Lynne has brought to this role and we wish her all the very best for the future. She has made an outstanding contribution to the development of the Society.

 

'I'm looking forward to welcoming Phil to the board and to working with Mai in her new role as Chair of the Remuneration Committee. We work very closely together as a board to set clear strategy and direction for the Society and I know that Phil and Mai will both play key roles in this.'

 

-Ends-

 

For further information, contact:

Dale Bihari, 07881 037945, dale.bihari@nationwide.co.uk

 

Notes:

 

Mai Fyfield biography

 

Mai is an economist who spent 20 years at Sky, most recently as Chief Commercial and Chief Strategy officer, advising the CEO and Board. She has been on the Nationwide board for four years and in the last year has been a member of the Remuneration Committee as well as representing the Voice of the Employee at the Board. She is a non-executive director of Roku Inc and a non-executive director of BBC Commercial Holdings Ltd.

 

 

Phil Rivett biography

 

Phil is a chartered accountant who recently retired after a forty year career at PricewaterhouseCoopers. He has been a senior partner in financial services for much of that time most recently as Chairman of the Global Financial Services Group and prior to that as Leader of Financial Services Assurance. He is an experienced advisor to major financial services providers in the UK and on a global basis.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABUGDIXGXBGCG
Date   Source Headline
12th Jun 20262:02 pmRNSPublication of a Prospectus
12th Jun 202611:31 amRNSPublication of Registration Document
12th Jun 202611:24 amRNSPublication of a Prospectus
9th Jun 202611:15 amRNSAdmission to Trading
8th Jun 202611:52 amRNSNOTICE TO NOTEHOLDERS
5th Jun 20262:58 pmRNSPublication of Final Terms
21st May 202612:33 pmRNSPublication of a Supplementary Prospectus
21st May 20267:00 amRNSPreliminary Results Announcement
6th May 20263:12 pmRNSPublication of Final Terms
21st Apr 20263:38 pmRNSPublication of Final Terms
21st Apr 202610:20 amRNSCancellation of Listing
20th Apr 202612:38 pmRNSNotice to Covered Bondholders
9th Apr 202611:06 amRNSPublication of a Supplementary Prospectus
7th Apr 20267:00 amRNSPart VII Transfer & Board changes
20th Mar 20268:48 amRNSRedemption of Securities
3rd Mar 202611:50 amRNSAdmission to Trading
3rd Mar 202611:44 amRNSAdmission to Trading
27th Feb 20265:18 pmRNSPublication of Final Terms
27th Feb 20263:56 pmRNSPublication of Final Terms
26th Feb 202611:00 amRNSPart VII Transfer
24th Feb 20269:51 amRNSAdmission to Trading
20th Feb 20269:47 amRNSPublication of Final Terms
19th Feb 202610:04 amRNSAdmission to Trading
17th Feb 20269:56 amRNSAdmission to Trading
17th Feb 20269:46 amRNSPublication of Final Terms
13th Feb 20262:04 pmRNSPublication of Final Terms
13th Feb 20268:15 amRNSPost Stabilisation Notice
3rd Feb 20262:41 pmRNSAdmission to Trading
30th Jan 20261:00 pmRNSPublication of Final Terms
16th Jan 20261:21 pmRNSPublication of Final Terms
8th Jan 20261:49 pmRNSPublication of Final Terms
8th Jan 20267:00 amRNSDirectorate change
7th Jan 202610:49 amRNSPre Stabilisation Notice
19th Dec 202511:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirectorate change
16th Dec 20252:42 pmRNSPublication of a Supplementary Prospectus
2nd Dec 20257:10 amRNSResponse to 2025 BOE Capital Stress Test Results
2nd Dec 20257:00 amRNSRevocation of Sub-consolidation Direction
20th Nov 202511:47 amRNSPublication of Supplement
20th Nov 20257:00 amRNSInterim Results September 2025
14th Nov 202511:00 amRNSPart VII Transfer
21st Oct 20251:08 pmRNSPublication of Final Terms
10th Oct 202512:52 pmRNSPublication of Final Terms
1st Oct 20257:00 amRNSConfirmation of Post-Offer Intention Statements
30th Sep 202510:03 amRNSBoard Changes
30th Sep 20259:43 amRNSBoard Changes
30th Sep 20257:00 amRNSBoard Changes
26th Sep 20252:49 pmRNSPublication of Final Terms
16th Sep 20251:48 pmRNSPublication of Final Terms
8th Sep 202511:27 amRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.